Correlation Between Petroleo Brasileiro and CanSino Biologics
Can any of the company-specific risk be diversified away by investing in both Petroleo Brasileiro and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petroleo Brasileiro and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Petroleo Brasileiro Petrobras and CanSino Biologics, you can compare the effects of market volatilities on Petroleo Brasileiro and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petroleo Brasileiro with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petroleo Brasileiro and CanSino Biologics.
Diversification Opportunities for Petroleo Brasileiro and CanSino Biologics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Petroleo and CanSino is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Petroleo Brasileiro Petrobras and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Petroleo Brasileiro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petroleo Brasileiro Petrobras are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Petroleo Brasileiro i.e., Petroleo Brasileiro and CanSino Biologics go up and down completely randomly.
Pair Corralation between Petroleo Brasileiro and CanSino Biologics
Considering the 90-day investment horizon Petroleo Brasileiro is expected to generate 576.75 times less return on investment than CanSino Biologics. But when comparing it to its historical volatility, Petroleo Brasileiro Petrobras is 2.48 times less risky than CanSino Biologics. It trades about 0.0 of its potential returns per unit of risk. CanSino Biologics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 270.00 in CanSino Biologics on September 24, 2024 and sell it today you would earn a total of 96.00 from holding CanSino Biologics or generate 35.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.42% |
Values | Daily Returns |
Petroleo Brasileiro Petrobras vs. CanSino Biologics
Performance |
Timeline |
Petroleo Brasileiro |
CanSino Biologics |
Petroleo Brasileiro and CanSino Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Petroleo Brasileiro and CanSino Biologics
The main advantage of trading using opposite Petroleo Brasileiro and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petroleo Brasileiro position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.Petroleo Brasileiro vs. Ecopetrol SA ADR | Petroleo Brasileiro vs. Equinor ASA ADR | Petroleo Brasileiro vs. Eni SpA ADR | Petroleo Brasileiro vs. Cenovus Energy |
CanSino Biologics vs. Merck Company | CanSino Biologics vs. Takeda Pharmaceutical | CanSino Biologics vs. HANSOH PHARMAC HD 00001 | CanSino Biologics vs. Guangzhou Baiyunshan Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
CEOs Directory Screen CEOs from public companies around the world |